Document
CVM Guidance for Industry #171 - Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated
ICR 202512-0910-001 · OMB 0910-0032 · Object 164466700.
Document Viewer [pdf]
Status: No verified local artifact is currently available. The document remains flagged for repair and upstream re-check.
Queue: Repair is queued and waiting for the next worker pass. (priority 140 · attempts 1 · next 2026-06-06 09:00:48)
Missing: pdf
No local or Spaces-backed artifact is available yet for this document.
Loading document viewer…
Document Metadata
| File Type | application/octet-stream |
|---|---|
| File Title | CVM Guidance for Industry #171 - Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated |
| Subject | Bioequivelance, Soluble, 171, Center for Veterinary Medicine, CVM, guidance, GFI, Aqueous, Type A Medicated Articles |
| Author | FDA CVM |
| File Modified | 2025-12-01 |
| File Created | 2023-06-08 |
| Conversion State | failed_conversion |